Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -12.21%.However, over the last six months, we can see a stronger performance of -9.57%. Over the last 30 days, the price of EWTX has leaped by -8.33%. And in the last five days, it has fallen by -1.60%.
Edgewise Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $38.12 on 11/11/24, while the lowest price for the same period was registered at $14.90 on 04/22/24.
52-week price history of EWTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Edgewise Therapeutics Inc’s current trading price is -38.51% away from its 52-week high, while its distance from the 52-week low is 57.32%. The stock’s price range during this period has varied between$14.90 and $38.12. The Edgewise Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.71 million for the day, a figure considerably higher than their average daily volume of 1.14 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Edgewise Therapeutics Inc (EWTX) has experienced a quarterly decline of -21.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.23B and boasts a workforce of 110 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 28.62, with a change in price of -9.88. Similarly, Edgewise Therapeutics Inc recorded 1,014,071 in trading volume during the last 100 days, posting a change of -29.65%.
EWTX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EWTX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
EWTX Stock Stochastic Average
Edgewise Therapeutics Inc’s raw stochastic average for the past 50 days is presently 20.93%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 22.01%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 12.69% and 11.94%, respectively.
